drugset / Trial / NCT01944007

Evaluation of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers

NCT01944007 ↗

Phase 1 Completed 25 enrolled Sorbent Therapeutics
RandomizedParallel-groupOpen-labelBasic science

Summary

This is a dose-escalation study to determine the effect of CLP in normal healthy volunteers.

Timeline

Start
2007-12
Primary completion
2008-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cross-Linked Polyelectrolyte (CLP) Other / unclassified 7.5 g Oral
Subject Cross-Linked Polyelectrolyte (CLP) Other / unclassified 15 g Oral
Subject Cross-Linked Polyelectrolyte (CLP) Other / unclassified 25 g Oral

Indications

No indication recorded.